Abstract
Protein kinase C (PKC) comprises a family of isoenzymes with serine/threonine kinase activity similar in molecular size, structure and mechanism of activation. This enzyme family is an important part of one of the major signal transduction pathways regulating many intracellular processes such as modulation of gene expression, cell proliferation and differentiation. PKC was identified as the major cellular receptor for skin tumor promoting phorbol esters and certain other compounds exhibiting skin tumor promoting bioactivity. Moreover, PKC is a target for molecules with antineoplastic activity like bryostatin. Thus by various investigators it is considered as a potential target for discovery and development of new anticancer drugs. On the other hand for PKC so far no potent and isoenzyme selective activators or inhibitors are known, and a 3-D structure of the enzyme is not available. Therefore a new technique of molecular modeling was investigated to design the agonist binding site of PKC: ‘Pseudoreceptor modeling’. It is a comprehensive strategy in the design of potent, selective and novel ligands for unknown receptors (Vedani et al., 1993). The new approach is focused on the binding site of the receptor and allows the construction of hypothetical 3-D-models of binding pockets using the directionality of receptor-ligand interactions (hydrogen bonds, metal-ligand interaction, hydrophobic interactions). In the investigation described an ensemble of six ligands, binding all specifically to the regulatory domain of the enzyme and representing together a pharmacophore model for activation of PKC, was successfully used. The pseudoreceptor model of PKC will be presented. It may be used as a surrogate of the agonist binding site of PKC to guide the synthesis of new and selective PKC-agonists allowing further investigation of PKC-isoforms in the signal transduction pathway. In addition it may be of assistance in the development for new antineoplastic drugs.
Represents person presenting Paper
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Basu, A. (1993) Pharmac. Ther.,59: 257–280
Tritton, T.R. and Hickman, J.A. (1990) Cancer Cell, 2: 95–105
Powis, G. (1991) Trends Pharmacol. Sci.,12: 188–193
Azzi, A., Boscoboinik, D. and Hensey, C. (1992) Eur. J. Biochem.,208: 547–557
Hug, H. and Sarre, T.F. (1993) Biochem J.,291: 329–343
Hecker, E. (1985) Arzneim.-Forsch./Drug Res.,35: 1890–1903
Takai, Y., Kishimoto, A., Inoue, M. and Nishizuka, Y. (1977) I, J. biol. Chem., 252: 7603–7609. II, J. Biol. Chem., 252: 7610–7616.
Nishizuka, Y. (1995) FASEB J.(in press).
Hecker, E. (1978) In: Carcinogenesis (Vol. 2), Mechanisms of tumor promotion and cocarcinogenesis, (Slaga T.J., Sivak A. and Boutwell R.K. Hrsg.), pp.11, Raven Press, New York.
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U. and Nishizuka, Y. (1982) J. Biol. Chem.,257: 7847–7851.
Berridge, M.J. (1987)A. Rev. Biochem.,56: 159–193.
Stabel, S. and Parker, P.J. (1991) Pharmac. Ther., 51: 71–95
Burns, D.J., Basta, P.V., Holmes, W.D., Ballas, L.M., Rankl, N.B., Barbee, J.L., Bell, R.M. and Loomis, C.R. (1992) In: Adenine Nucleotides in Cellular Energy Transfer and Signal Transduction, (Papa, S., Azzi, A. and Tager, J.M. ed.) pp. 207–217, Birkhäuser Verlag, Basel/Switzerland.
Blumberg, P.M. (1988) Cancer Res., 48: 1–8.
Rando, R.R. and Kishi, Y. (1992) Biochemistry, 31: 2211–2218
Burns, D.J. and Bell, R.M. (1991) J Biol. Chem.,266: 18330–18338
Ahmed, S., Kozma, R. Lee, J., Monfries, C., Harden, N. and Lim, L. (1991) Biochemical J.,55: 233–241
Vedani, A., Zbinden, P. and Synder, P. (1993) J. Receptor Res,13: 163–177
Taylor, R. and Kennord, O. (1984) J. Acc. Chem. Res. 17: 320–326
Murry-Rust, P. and Glusker, J.P. (1984) J. Am. Chem. Soc. 106: 1018–1025
Vedani, A. and Dunitz, J.D. (1985) J. Am. Chem. Soc. 107: 7653–7958
Baker, E.N. and Hubbard, R.E. (1984) Prog. Biophys. Mol. Biol. 44: 97–179
Tintelnot, M. and Andrew, P. (1992) J. Comput. Aided Mol. Design. 3: 67–84
v.d. Lieth, C.W., Krauter, G. and Hecker, E. (1995) In: Novel Appraoches in Anticancer Drug Design, Molecular Modelling-New Treatment Strategies. Contrib. Oncol., (Zeller W.J., D’Incali, M. and Newell, D.R. ed.) 49: 25–39,.Basel, Karger.
Krauter, G. (1993) Über Struktur und Wirkung von Agonisten der Protein Kinase C: Untersuchungen mittels klassischer quantitativer Strukturwirkungsbeziehungen (QSAR) und rechnerunterstützter molekularer Modellierungen; doctoral thesis, Naturwissenschaftlich-Mathematische Gesamtfakultät, University of Heidelberg
Rippmann, F. (1990) Quant. Struct. -Act. Relat. 9: 1–5.
Hubbard, S.R., Bishop, W.R., Kirschmeier, P., Goerge, S.J., Cramer, S.P. and Hendrickson, W.A. (1991) Science, 254: 1776–1779
Böhm, H.J. (1992) J. Comput. Aided Mol. Design, 6: 61–78
Böhm, H.J. (1992) J. Comput. Aided Mol. Design, 6: 593–606
Rotstein, S.H. and Murcko, M.A. (1993) J. Comput. Aided Mol. Design, 7: 23–43.
Eisen, M.B., Wiley, D.C., Karplus, M. and Hubbard, R.E. (1994) Structure, Function, and Genetics, 19: 199–221
Lawrence, M.C. and Davis, P.C. (1992) Proteins: Structure,Function, and Genetics, 12: 31–41.
Teng, K., Marquez, V.E., Milne, G.W.A., Barchi, J.J., Kazanietz, M.G., Lewin, N.E., Blumberg, P.M. and Abushanab, E. (1992) J. Am. Chem. Soc., 114: 1059–1070
Ono, Y., Fujii, T., Ogita, K., Kikkawa, U., Igarishi, K. and Nishizuka, Y. (1987) FEBS Lett. 226: 125–128
Osada, S., Mizuno, K., Saido, T. C., Akita, Y., Suzuki, K., Kuroki, T. and Ohno, S. (1990) J. Biol. Chem., 265: 22434–22440
Ohno, S., Kawasaki, H., Imajoh, S., Suzuki, K., Inagaki, M., Yokokura, H., Sakoh, T. and Hidaka, H. (1987) Nature, 325: 161–166
Bacher, N., Zisman, Y., Berent, E. and Livneh, E. (1991) Molecular and Cellular Biology, 11: 126–133
Coussen, L., Parker, P.J., Rhee, L., Yang-Feng, T.L., Chen, E., Waterfield, M.D., Franke, U. and Ullrich, A. (1986) Science, 233: 859–865
Tabuse, Y., Nishiwaki, K. and Miwa, J. (1989) Science, 243: 1713–1716
Chen, K., Peng, Z., Lavu, S. and Kung, H. (1989) Sec. Mess. Phosphoprot., 12: 251–260
Schaeffer, E., Smith, D., Mardon, G., Quinn, W. and Zuker, C. (1989) Cell, 57: 403–412
Maruyama, N.I. and Brenner, S. (1991) Proc. Natl. Acad. Sci. USA; 55: 5729–5733
Hall, C., Monfries, C., Smith, P., Lim, H.H., Kozma, R., Ahmed, S., Vanniasingham, V., Leung, T. and Lim, L. (1990) J. Mol. Biol., 211: 11–16
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Krauter, G., von der Lieth, C.W., Hecker, E. (1996). New Insights into the Molecular Structure of the Agonists Binding Site of Protein Kinase C by Pseudoreceptor Modeling. In: Zaidi, Z.H., Smith, D.L. (eds) Protein Structure — Function Relationship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0359-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0359-6_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8015-3
Online ISBN: 978-1-4613-0359-6
eBook Packages: Springer Book Archive